IGF2BP2 and sarcopenia: In conclusion, this study revealed that the overexpression of Igf2bp2 in C2C12 cells using a let-7e-5p inhibitor improves sarcopenia mainly via suppression of genes associated with muscle atrophy and enhanced mitochondrial function.